Clearstead Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8K Buy
107
+2
+2% +$207 ﹤0.01% 605
2026
Q1
$10.2K Buy
105
+15
+17% +$1.54K ﹤0.01% 574
2025
Q4
$9.55K Buy
90
+21
+30% +$2.43K ﹤0.01% 599
2025
Q3
$8.77K Sell
69
-8
-10% -$952 ﹤0.01% 615
2025
Q2
$9.44K Buy
77
+8
+12% +$914 ﹤0.01% 606
2025
Q1
$6.99K Buy
+69
New +$6.74K ﹤0.01% 528

Other funds holding EHC

Clearstead Trust's EHC Position: Q2 2026 in Review

Clearstead Trust increased its Encompass Health (EHC) stake by 1.9% in Q2 2026, buying an estimated $207 and bringing the position to 107 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #605.

Clearstead Trust first reported a position in EHC in Q1 2025 and has held it in 6 quarters since. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Clearstead Trust held 107 shares of Encompass Health worth $10.8K as of Q2 2026.
  • Clearstead Trust bought 2 Encompass Health shares in Q2 2026, an estimated $207.
  • Encompass Health made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #605 holding.
  • Clearstead Trust first reported a position in Encompass Health in Q1 2025 and has held it in 6 quarters since.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.